{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:23:47Z","timestamp":1781177027501,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.11.014","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:43:15Z","timestamp":1732077795000},"page":"102564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Teicoplanin 24-h loading dose regimen using a decision tree model to target serum trough concentration of 15\u201330\u00a0\u03bcg\/mL: A retrospective study"],"prefix":"10.1016","volume":"31","author":[{"given":"Shoji","family":"Kondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0693-1896","authenticated-orcid":false,"given":"Kazutaka","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Jono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.11.014_bib1","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1128\/AAC.00341-09","article-title":"Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis","volume":"53","author":"Svetitsky","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib2","first-page":"10","article-title":"Serum concentration of glycopeptide antibiotics and its relation to development of adverse events","volume":"27","author":"Sumi","year":"2010","journal-title":"Jpn J Ther Drug Monit"},{"key":"10.1016\/j.jiac.2024.11.014_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkab499","article-title":"Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"77","author":"Hanai","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jac\/dkg147","article-title":"Teicoplanin therapeutic drug monitoring in critically ill patients: a retrospective study emphasizing the importance of a loading dose","volume":"51","author":"Pea","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib5","first-page":"8","article-title":"Clinical efficacy of high treatment with teicoplanin (TEIC) against MRSA infections and trough concentration of TEIC","volume":"55","author":"Ueda","year":"2007","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jiac.2015.02.002","article-title":"Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections","volume":"21","author":"Nakamura","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jiac.2013.08.006","article-title":"High-dose regimen to achieve novel target trough concentration in teicoplanin","volume":"20","author":"Ueda","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib8","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1248\/bpb.b22-00305","article-title":"Machine learning-based model for estimating vancomycin maintenance dose to target the area under the concentration curve of 400-600 mg\u00b7h\/L in Japanese patients","volume":"45","author":"Miyai","year":"2022","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jiac.2024.11.014_bib9","first-page":"415","article-title":"Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia","volume":"79","author":"Inoue","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2024.11.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106506","article-title":"Prediction of plasma trough concentration of voriconazole in adult patients using machine learning","volume":"188","author":"Cheng","year":"2023","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.jiac.2024.11.014_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.csbj.2016.12.005","article-title":"Machine learning and data mining methods in diabetes research","volume":"15","author":"Kavakiotis","year":"2017","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.jiac.2024.11.014_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF01059273","article-title":"Pharmacokinetics of teicoplanin in man after intravenous administration","volume":"12","author":"Traina","year":"1984","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.jiac.2024.11.014_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jiac.2024.11.014_bib14","first-page":"1","article-title":"Population pharmacokinetics of teicoplanin in adult patients","volume":"54","author":"Nakayama","year":"2006","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5414\/CP201739","article-title":"Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection","volume":"51","author":"Ogawa","year":"2013","journal-title":"Int J Clin Pharm Ther"},{"key":"10.1016\/j.jiac.2024.11.014_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00228-024-03638-0","article-title":"Association of the predicted free blood concentration of teicoplanin with the development of renal dysfunction","volume":"80","author":"Sugiyama","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2024.11.014_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00544566","article-title":"Binding of teicoplanin to human serum albumin","volume":"33","author":"Assandri","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2024.11.014_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02466-16","article-title":"Variability in trough total and unbound teicoplanin concentrations and achievement of therapeutic drug monitoring targets in adult patients with hematological malignancy","volume":"61","author":"Byrne","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2024.11.014_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3918\/jsicm.19.39","article-title":"Evaluation of loading dose of teicoplanin targeting therapeutic trough concentration and safety","volume":"19","author":"Yanai","year":"2012","journal-title":"J Jpn Soc Intensive Care Med"},{"key":"10.1016\/j.jiac.2024.11.014_bib20","article-title":"Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.jiac.2024.11.014_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/00368504241274023","article-title":"The role of serum albumin in critical illness, predicting poor outcomes, and exploring the therapeutic potential of albumin supplementation","volume":"107","author":"Rabi","year":"2024","journal-title":"Sci Prog"},{"key":"10.1016\/j.jiac.2024.11.014_bib22","article-title":"Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2024.11.014_bib23","series-title":"Teicoplanin: the first decade","author":"Wilson","year":"1997"},{"key":"10.1016\/j.jiac.2024.11.014_bib24","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/jcpt.13011","article-title":"Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation","volume":"44","author":"Kato-Hayashi","year":"2019","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.jiac.2024.11.014_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106940","article-title":"Safety of high loading doses of teicoplanin: POSY-TEICO, a prospective, multicentre, observational study","volume":"62","author":"Gauzit","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2024.11.014_bib26","first-page":"15","article-title":"Pharmacokinetic\/pharmacodynamic analysis of teicoplanin in patients with MRSA infections","volume":"8","author":"Matsumoto","year":"2016","journal-title":"Clin Pharmacol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:42:31Z","timestamp":1747240951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X24003118"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.014","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Teicoplanin 24-h loading dose regimen using a decision tree model to target serum trough concentration of 15\u201330\u00a0\u03bcg\/mL: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102564"}}